Feasibility of nitric oxide administration by oxygen hood in neonatal pulmonary hypertension

Journal of Perinatology

Volumn 22, Issue 1, 2002, Pages 50-56

  Ambalavanan, Namasivayam ^a   St John, Elaine ^a   Carlo, Waldemar A ^a   Bulger, Arlene ^a   Philips III, Joseph B ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITROGEN; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EXPOSURE; FEASIBILITY STUDY; HEART OUTPUT; HYPOXIA; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; NONHUMAN; PULMONARY HYPERTENSION; STREPTOCOCCUS AGALACTIAE; SUCTION; SWINE;

ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; HEMODYNAMIC PROCESSES; HYPERTENSION, PULMONARY; NITRIC OXIDE; PULMONARY ARTERY; SWINE; VASCULAR RESISTANCE;

EID: 0036177455     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210652     Document Type: Article

References (23)

1. Persistent pulmonary hypertension of the newborn. The black box revisited
2. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure
3. Randomized multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn
4. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension
5. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn
6. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn
7. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double-masked, placebo-controlled, dose-response, multicenter study
8. Inhaled nitric oxide: A tenth anniversary observation
9. Bronchopulmonary dysplasia
10. Ventilatory management in neonates. Science or art?
11. Role of capsule in pulmonary hypertension induced by group B streptococcus
12. Persistent pulmonary hypertension of the newborn. Role of nitric oxide and endothelin in pathophysiology and treatment
13. Thromboxane synthesis inhibition reverses group B Streptococcus-induced pulmonary hypertension
14. Inhaled nitric oxide therapy via nasopharyngeal tube in an infant with end-stage pulmonary hypertension
15. Alae nasi activation (nasal flaring) decreases nasal resistance in preterm infants
16. Nasal airway resistance in the newborn
17. Acute hemodynamic effects of pulsed delivery of low flow nasal nitric oxide in children with pulmonary hypertension
18. Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn
19. Hemodynamics and oxygenation changes induced by the discontinuation of low-dose inhalational nitric oxide in newborn infants
20. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose response